Myrislignan
CAS No. 171485-39-5
Myrislignan( —— )
Catalog No. M21442 CAS No. 171485-39-5
Myrislignan has anti-inflammatory and anti-cancer activities it inhibited NF-κB signalling pathway activation inhibited the proliferation of A549 cells in a dose- and time-dependent manner it also significantly induced apoptosis and cell cycle arrest in A549 cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 85 | In Stock |
|
10MG | 132 | In Stock |
|
25MG | 237 | In Stock |
|
50MG | 385 | In Stock |
|
100MG | 561 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMyrislignan
-
NoteResearch use only, not for human use.
-
Brief DescriptionMyrislignan has anti-inflammatory and anti-cancer activities it inhibited NF-κB signalling pathway activation inhibited the proliferation of A549 cells in a dose- and time-dependent manner it also significantly induced apoptosis and cell cycle arrest in A549 cells.
-
DescriptionMyrislignan has anti-inflammatory and anti-cancer activities it inhibited NF-κB signalling pathway activation inhibited the proliferation of A549 cells in a dose- and time-dependent manner it also significantly induced apoptosis and cell cycle arrest in A549 cells.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetNF-κB
-
RecptorNF-κB|Apoptosis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number171485-39-5
-
Formula Weight374.4
-
Molecular FormulaC21H26O6
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (267.07 mM)
-
SMILESC[C@@H]([C@@H](c(cc1)cc(OC)c1O)O)Oc(c(OC)cc(CC=C)c1)c1OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lu X G Yang L Chen J X et al. The action and mechanism of myrislignan on A549 cells in vitro and in vivo[J]. Journal of Natural Medicines 2016 71(1):76.
molnova catalog
related products
-
NF-κB-IN-1
NF-κB-IN-1 is a potent NF-κB signaling pathway inhibitor. It is a 4-arylidene crucumin analogue. NF-κB-IN-1 directly inhibits IKK to block NF-κB activation.
-
SR12460
SR12460 (SR-12460) is a novel NF-κB essential modulator (NEMO)-binding domain (NBD) mimetic for inhibiting IKK/NF-κB activation.
-
Helenalin
Helenalin (NSC 85236) is a sesquiterpene lactone that covalently targets Cys38 on p65 transcription factor in the canonical NF-κB signaling pathway.